Literature DB >> 22009261

CAPER-α alternative splicing regulates the expression of vascular endothelial growth factor₁₆₅ in Ewing sarcoma cells.

Gangxiong Huang1, Zhichao Zhou, Hua Wang, Eugenie S Kleinerman.   

Abstract

BACKGROUND: TC-71 Ewing sarcoma cells overexpress vascular endothelial growth factor (VEGF) with a shift from the 189 to the 165 isoform.
METHODS: The effect of CAPER-α on the expression of the VEGF isoforms, tumor growth, and vessel density was analyzed after transfection of TC-71 cells with CAPER-α cDNA or siRNA.
RESULTS: CAPER-α correlated inversely with the VEGF(165) /VEGF(189) mRNA ratio. Up-regulation of CAPER-α resulted in decreased tumor growth, tumor vessel density, and chemotactic activity of the cell's supernatant. CAPER-α expression was regulated by EWS/FLI-1 through a protein-protein interaction.
CONCLUSIONS: Increased VEGF(165) expression is secondary to the down-regulation of CAPER-α by EWS/FLI-1. CAPER-α mediates alternative splicing and controls the shift from VEGF(189) to VEGF(165) .
Copyright © 2011 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22009261      PMCID: PMC3262942          DOI: 10.1002/cncr.26488

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  38 in total

1.  Molecular cloning and characterization of CAPER, a novel coactivator of activating protein-1 and estrogen receptors.

Authors:  Dong-Ju Jung; Soon-Young Na; Doe Sun Na; Jae Woon Lee
Journal:  J Biol Chem       Date:  2001-11-09       Impact factor: 5.157

Review 2.  Alternative pre-mRNA splicing and proteome expansion in metazoans.

Authors:  Tom Maniatis; Bosiljka Tasic
Journal:  Nature       Date:  2002-07-11       Impact factor: 49.962

3.  Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference.

Authors:  Maciej Wiznerowicz; Didier Trono
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

4.  EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3.

Authors:  Alexandre Prieur; Franck Tirode; Pinchas Cohen; Olivier Delattre
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

5.  Vascular endothelial growth factor expression is up-regulated by EWS-ETS oncoproteins and Sp1 and may represent an independent predictor of survival in Ewing's sarcoma.

Authors:  Bruno Fuchs; Carrie Y Inwards; Ralf Janknecht
Journal:  Clin Cancer Res       Date:  2004-02-15       Impact factor: 12.531

6.  Vascular endothelial growth factor (VEGF) mRNA splice variants are differentially expressed in human blastocysts.

Authors:  J S Krüssel; B Behr; A A Milki; J Hirchenhain; Y Wen; P Bielfeld; M Lake Polan
Journal:  Mol Hum Reprod       Date:  2001-01       Impact factor: 4.025

Review 7.  Pathological significance of vascular endothelial growth factor A isoform expression in human cancer.

Authors:  Masato Nakamura; Yoshiyuki Abe; Tetsuji Tokunaga
Journal:  Pathol Int       Date:  2002 May-Jun       Impact factor: 2.534

8.  The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA.

Authors:  K A Houck; N Ferrara; J Winer; G Cachianes; B Li; D W Leung
Journal:  Mol Endocrinol       Date:  1991-12

9.  Selective usage of D-Type cyclins by Ewing's tumors and rhabdomyosarcomas.

Authors:  Jingsong Zhang; Siwen Hu; Deborah E Schofield; Poul H B Sorensen; Timothy J Triche
Journal:  Cancer Res       Date:  2004-09-01       Impact factor: 12.701

10.  Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels.

Authors:  H F Dvorak; T M Sioussat; L F Brown; B Berse; J A Nagy; A Sotrel; E J Manseau; L Van de Water; D R Senger
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

View more
  27 in total

Review 1.  Diverse regulation of 3' splice site usage.

Authors:  Muhammad Sohail; Jiuyong Xie
Journal:  Cell Mol Life Sci       Date:  2015-09-14       Impact factor: 9.261

2.  UHM-ULM interactions in the RBM39-U2AF65 splicing-factor complex.

Authors:  Galina A Stepanyuk; Pedro Serrano; Eigen Peralta; Carol L Farr; Herbert L Axelrod; Michael Geralt; Debanu Das; Hsiu-Ju Chiu; Lukasz Jaroszewski; Ashley M Deacon; Scott A Lesley; Marc-André Elsliger; Adam Godzik; Ian A Wilson; Kurt Wüthrich; Daniel R Salomon; James R Williamson
Journal:  Acta Crystallogr D Struct Biol       Date:  2016-03-24       Impact factor: 7.652

3.  U2AF65 assemblies drive sequence-specific splice site recognition.

Authors:  Manel Tari; Valérie Manceau; Jean de Matha Salone; Asaki Kobayashi; David Pastré; Alexandre Maucuer
Journal:  EMBO Rep       Date:  2019-07-04       Impact factor: 8.807

4.  Cancer-relevant splicing factor CAPERα engages the essential splicing factor SF3b155 in a specific ternary complex.

Authors:  Sarah Loerch; Alexandre Maucuer; Valérie Manceau; Michael R Green; Clara L Kielkopf
Journal:  J Biol Chem       Date:  2014-05-02       Impact factor: 5.157

5.  The RNA-binding protein caper is required for sensory neuron development in Drosophila melanogaster.

Authors:  Eugenia C Olesnicky; Jeremy M Bono; Laura Bell; Logan T Schachtner; Meghan C Lybecker
Journal:  Dev Dyn       Date:  2017-06-29       Impact factor: 3.780

6.  Selective degradation of splicing factor CAPERα by anticancer sulfonamides.

Authors:  Taisuke Uehara; Yukinori Minoshima; Koji Sagane; Naoko Hata Sugi; Kaoru Ogawa Mitsuhashi; Noboru Yamamoto; Hiroshi Kamiyama; Kentaro Takahashi; Yoshihiko Kotake; Mai Uesugi; Akira Yokoi; Atsushi Inoue; Taku Yoshida; Miyuki Mabuchi; Akito Tanaka; Takashi Owa
Journal:  Nat Chem Biol       Date:  2017-04-24       Impact factor: 15.040

7.  Ewing's sarcoma: overcoming the therapeutic plateau.

Authors:  Vivek Subbiah; Razelle Kurzrock
Journal:  Discov Med       Date:  2012-06       Impact factor: 2.970

8.  CAPER, a novel regulator of human breast cancer progression.

Authors:  Isabelle Mercier; Donna M Gonzales; Kevin Quann; Timothy G Pestell; Alexander Molchansky; Federica Sotgia; James Hulit; Ricardo Gandara; Chenguang Wang; Richard G Pestell; Michael P Lisanti; Jean-François Jasmin
Journal:  Cell Cycle       Date:  2014-02-17       Impact factor: 4.534

Review 9.  Twenty Years on: What Do We Really Know about Ewing Sarcoma and What Is the Path Forward?

Authors:  Elizabeth R Lawlor; Poul H Sorensen
Journal:  Crit Rev Oncog       Date:  2015

10.  Anopheles NF-κB-regulated splicing factors direct pathogen-specific repertoires of the hypervariable pattern recognition receptor AgDscam.

Authors:  Yuemei Dong; Chris M Cirimotich; Andrew Pike; Ramesh Chandra; George Dimopoulos
Journal:  Cell Host Microbe       Date:  2012-10-18       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.